PHILADELPHIA (KYW Newsradio) — As we learn more about COVID-19, we are also learning more about the vaccine.
The pace of coronavirus vaccine development was unprecedented, and scientists are still looking at data to ensure safety and look out for risks.
One of the biggest questions about vaccines surrounds pregnancy. The Pfizer vaccine continues to be closely studied in pregnant women, and information is coming from all over the world, including the U.S., Canada, Argentina, Brazil, the U.K. and Spain.
After delivery, infants will be monitored for safety and for the transfer of potentially protective antibodies until they're about 6 months old.
Another group being studied is children between ages 5 and 11.
KYW Newsradio’s Medical Reports are sponsored by Independence Blue Cross.